1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with suprofen in 1 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (suprofen) | Trials (suprofen) | Recent Studies (post-2010) (suprofen) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 237 | 50 | 18 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| van Delft, JL; van Haeringen, NJ; Verbey, NL | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and suprofen
| Article | Year |
|---|---|
Antagonists and inhibitors of lipid mediators in experimental inflammation of the cornea.
Topics: Animals; Chromones; Diterpenes; Eicosapentaenoic Acid; Fluorometholone; Ginkgolides; Keratitis; Lactones; Linolenic Acids; Lipids; Lipoxygenase Inhibitors; Male; Platelet Activating Factor; Rabbits; SRS-A; Suprofen | 1993 |